Ananda Wijewickrama
Biographic Data
| ID | 7292637 |
|---|---|
| NAME | Ananda Wijewickrama |
| GIVEN NAMES | Ananda |
| FAMILY NAME | Wijewickrama |
| SIGNATURE | WIJEWICKRAMA A |
| ORCID | 0000-0003-2723-1813 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Identifying the strains of dengue circulating in the western province of Sri Lanka during 2019–2022
A study conducted from July 2019 to May 2022 at several hospitals in the Western Province, Sri Lanka, focused on dengue virus strains during the COVID-19 pandemic. Among 417 febrile patients, 47% were PCR-positive for dengue. Serotyping revealed DENV-1 (12.8%), DENV-2 (46.4%), DENV-3 (37.2%), and DENV-4 (3.6%). Sequencing identified two genotypically distinct variants of DENV-3 and two genotypically distinct variants of DENV-1, while DENV-2 showe…
Efficacy and safety of Link Natural Sudarshana, an Ayurvedic herbal preparation in Covid-19 patients
LNS is safe to use in COVID-19 patients and accelerated the decline in viral load, relieved symptoms, reduced CRP levels and reversed lymphopenia earlier, when compared to the placebo
No prominent works on this page.
Identifying the strains of dengue circulating in the western province of Sri Lanka during 2019–2022
A study conducted from July 2019 to May 2022 at several hospitals in the Western Province, Sri Lanka, focused on dengue virus strains during the COVID-19 pandemic. Among 417 febrile patients, 47% were PCR-positive for dengue. Serotyping revealed DENV-1 (12.8%), DENV-2 (46.4%), DENV-3 (37.2%), and DENV-4 (3.6%). Sequencing identified two genotypically distinct variants of DENV-3 and two genotypically distinct variants of DENV-1, while DENV-2 showe…
Efficacy and safety of Link Natural Sudarshana, an Ayurvedic herbal preparation in Covid-19 patients
LNS is safe to use in COVID-19 patients and accelerated the decline in viral load, relieved symptoms, reduced CRP levels and reversed lymphopenia earlier, when compared to the placebo
Internal Medicine (2 works) · Medicine (2 works) · Adverse effect (1 work) · Alternative medicine (1 work) · Andrographolide Research and Applications (1 work) · Biology (1 work) · Clinical endpoint (1 work) · Clinical trial (1 work) · COVID-19 Clinical Research Studies (1 work) · Dengue fever (1 work)